ReflexMD advertises flat monthly GLP-1 rates—$299 for compounded semaglutide, $399 for tirzepatide—but does not publish whether those rates hold steady when your prescriber increases your dose.

Most telehealth GLP-1 programs advertise a medication price, but the true monthly cost often includes separate membership fees, dose-tiered pricing, lab charges, or higher refill rates. We break down the all-in recurring cost across fourteen programs.

Fridays Health publishes plan-tier pricing but does not document whether your monthly rate changes when your clinician increases your semaglutide or tirzepatide dose. PlexusDx guarantees the same price at every dose.

A budgeting worksheet for MEDVi beyond the first month: the formula, the inputs verified on September 22, 2026, and worked totals for three, six, and twelve billing cycles for new patients and refill-only patients, with the same math applied to PlexusDx so the two can be compared on equal terms.

Trava does not publish itemized pricing for its compounded GLP-1 program. This analysis explains what is known, what remains unclear, and how to evaluate alternatives with transparent, checkout-verified rates.

Remedy Meds charges $189/month for its microdose plan and $299-$399/month for standard-dose compounds. PlexusDx offers identical compounded GLP-1 programs at $129-$289/month with published pricing and multiple format options.

Pomegranate Health advertises $119/month semaglutide and $149/month tirzepatide. We compare ten programs offering compounded GLP-1 injections on month-to-month billing and show 12-month costs so you can confirm whether that low rate holds up.

Remedy Meds publishes no product prices until after intake, but verified evidence shows $189/month microdose and $299–$399/month standard-dose figures. We compare those rates against PlexusDx's published ladder.